Cardium Therapeutics, Inc. (CXM) Scheduled to Make Presentation at the Rodman & Renshaw Annual 2012 Healthcare Investment Conference

Cardium Therapeutics today announced that Chairman & CEO Christopher J. Reinhard will be giving a presentation at the Rodman & Renshaw Annual Healthcare Investment Conference on Monday, September 10, 2012, at 3:15 p.m. Eastern Time. The conference is being held September 9-11, 2012, at the Waldorf-Astoria Hotel in New York City.

An audio webcast of the company’s presentation will be available both live and by replay at as well as the Investors section of Cardium’s website at An updated investor presentation is now available on Cardium’s website at
Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium’s current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium Health Sciences healthy lifestyle product platform.
To learn more about the company, visit

Please see disclaimer on the MissionIR website: